More importantly, the study showed for the first time that anti-inflammatory mediators such as IL-1ra, IL-10, and adiponectin, and anti-fibrotic mediators such as Klotho, Relaxin 1, Relaxin 319,20 are reduced in the older adults with MS. Here, RLN1 is linked to myeloid sarcoma.